Related Experiment Videos
[Adenovirus, a gene therapy vector: application to lung diseases]
M Perricaudet1, L D Stratford-Perricaudet
1U.A. 1301 du CNRS : Génétique des Virus Oncogènes, Villejuif.
Bulletin De L'Academie Nationale De Medecine
|March 1, 1995
Summary
Adenovirus vectors offer an efficient in vivo gene therapy method for quiescent tissues. Replication-incompetent adenoviruses successfully delivered genes to various organs, showing promise for treating cystic fibrosis and lung cancer.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Context:
- Gene therapy for quiescent tissues requires novel strategies beyond ex vivo methods.
- Direct in vivo gene delivery offers technical advantages but needs high-titer vectors.
- Retroviral limitations necessitate exploring alternative viral vectors.
Purpose:
- To investigate the potential of adenovirus as a gene therapy vector for quiescent tissues.
- To evaluate the efficiency and duration of gene transfer using replication-incompetent adenoviruses.
- To explore adenovirus-based gene therapy for diseases like cystic fibrosis and lung cancer.
Summary:
- Adenoviruses, targeting epithelial cells with a large DNA genome, are suitable for gene therapy.
- Replication-defective adenoviruses efficiently transferred genes to liver, muscle, lung, and brain tissues long-term.
- Adenovirus' natural lung tropism makes it a promising vector for cystic fibrosis and lung cancer gene therapy.
Impact:
- Demonstrates the efficacy of replication-incompetent adenoviruses for sustained gene transfer in multiple organs.
- Highlights adenovirus as a viable vector for in vivo gene therapy, overcoming retroviral restrictions.
- Proposes adenovirus-mediated CFTR gene delivery for treating cystic fibrosis and lung cancer.